Article

Symposiym focuses on reframing glaucoma evaluation

Ophthalmologists can improve glaucoma care by employing a systematic approach to optic nerve evaluation to determine disease severity and risk of progression, according to speakers at a continuing medical education symposium held during the American Academy of Ophthalmology meeting.

Ophthalmologists can improve glaucoma care by employing a systematic approach to optic nerve evaluation to determine disease severity and risk of progression, according to speakers at a continuing medical education symposium held during the American Academy of Ophthalmology meeting.

The moderator for the program was Robert N. Weinreb, MD, professor of ophthalmology, University of California, San Diego, and director, Hamilton Glaucoma Center, La Jolla, CA.

"Glaucoma is now defined as an optic nerve disorder, and that means you may or may not have functional visual field loss although you can see damage to the optic nerve," Dr. Coleman said. She is professor of ophthalmology, Frances and Ray Stark Chair in Ophthalmology, Jules Stein Eye Institute, David Geffen School of Medicine at UCLA, Los Angeles.

She added that evidence-based glaucoma management guidelines recommend careful evaluation of the optic nerve and RNFL as well as the visual field during both diagnosis and follow-up. The results of each examination should be documented in charts through a description and a detailed drawing or optic disc photographs.

The baseline examination can detect disc hemorrhages and nerve fiber layer defects and help the clinician diagnose early glaucomatous optic nerve damage. At follow-up, the examination can help the clinician determine whether progression has occurred or if a patient seems to be at risk of progression.

Ideally, optic nerve examination should take place at regular intervals, but Dr. Coleman acknowledged that this doesn't always happen in the busy practice setting. Dilation and testing take up more of the patient's time and may trigger complaints of discomfort. Also, the increased exam time can affect scheduling.

However, the benefits of optic nerve examination are significant and outweigh the costs, Dr. Coleman said.

"Glaucoma is an optic neuropathy, and you can't diagnose an optic neuropathy without looking at the optic nerve," she added.

Conducting such examinations will help clinicians improve their diagnostic skills, detect more cases of glaucoma and miss fewer cases, help more patients, and reduce progression, she added.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.